Fig. 3
From: Sulfonohydrazide as a potential inhibitor of SARS-CoV-2 infection
Effect of compound 24 at different viral time points in compound-treated SARS-CoV-2 infected Vero cells. Log fold-change was calculated compared to virus-treated cells before (prophylactic), during (entry), and after (therapeutic) compound treatments at 83 µM concentration, and the mean fold-change was plotted. The asterisk indicates the significance between different groups. One-way ANOVA, followed by Bonferroni’s Multiple Comparison Test was performed as a statistical analysis (∗p < 0.05, ∗∗p < 0.01, ***p < 0.001).
